Amy Thomson

Why organisations work with Amy Thomson

• A founder who has actually built and sold in consumer markets twice, once in brand communications with Nike, Microsoft and Instagram as clients, and once in femtech with a venture-backed app and a Penguin-published book underneath it.
• Specific operating knowledge of category creation in stigmatised territory: how to position, fundraise, and market around hormonal health without the wellness-industry shortcuts that erode trust.
• A published Penguin title grounded in research from gynaecologists, endocrinologists and nutritionists, which means consumer health and pharma teams get a speaker with editorial credibility, not just a founder pitch.
• A first-person account of hormonal burnout as a CEO that resonates with leadership audiences, then connects to a commercial argument about why workforce health is being misread by employers.

Biography highlights

• Founder and CEO, Moody Month, awarded “Top Female Health App” by Apple
• Author, Moody: A 21st Century Hormone Guide, Penguin
• Founder, SEEN brand agency, clients including Nike, Microsoft, RBS, Instagram and Diageo; sold to Captivate Group
• Co-founder, Future Girl Corp, with Sharmadean Reid, partnered with Google and Diageo
• Sociology, Goldsmiths, University of London
• Keynote engagements include Apple HQ and Vogue

Biography

Most consumer health products built for women have been designed without a serious commercial thesis attached to female physiology. Thomson started Moody Month to close that gap, building a venture-backed app that tracks hormonal and mental health across the menstrual cycle. Apple named it “Top Female Health App” and featured it on the App Store Today Tab.

Her route to femtech was operational. She founded SEEN at 23, a brand and content agency working with Nike, Microsoft, RBS, Instagram and Diageo, before selling the company to Captivate Group. A hormonal burnout, driven by years of high-intensity client work, forced her to stop. The decision to study what had happened to her body became the foundation for Moody and for her Penguin book, Moody: A 21st Century Hormone Guide, which draws on gynaecologists, endocrinologists and nutritionists rather than wellness orthodoxy.

That dual track, agency exit then femtech category creation, gives her a particular usefulness to consumer health, FMCG and pharma teams trying to build credibly in physiology markets. She has co-founded Future Girl Corp with Sharmadean Reid, partnered Google and Diageo into that programme, and raised institutional capital around a product category most investors still find awkward to underwrite. The commercial argument she makes is concrete: hormonal health is a consumer market that has been mispriced by incumbents and underserved by wellness branding.

For leadership audiences, the burnout story carries a sharper edge than the wellness circuit typically allows. It is told by a founder who walked away from a profitable agency, rebuilt around a physiological problem her own body forced her to take seriously, and then commercialised the answer.

Key speaking topics

• Femtech and women’s health as a commercial category
• Consumer brand building in stigmatised markets
• Founder-led category creation
• Hormonal health, data and machine learning
• Raising venture capital as a female founder
• Burnout, physiology and executive performance

Ideal for

• CMOs, brand directors and consumer innovation teams in FMCG, pharma and health
• Investor audiences in femtech, digital health and consumer technology
• Founder programmes and scale-up leadership networks
• Boards and leadership teams reviewing workforce health beyond standard wellbeing programming

Audience outcomes

• A working commercial frame for women’s health as a consumer category, not a CSR line
• A founder’s account of fundraising in stigmatised markets, with the patterns that move investors
• A first-person view of hormonal burnout at CEO level and what it changed about her operating model
• A clearer read on why hormonal data is becoming a serious input for consumer product and workforce health